The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Ola Ekström

Research student

Default user image.

N1-methylnicotinamide is a signalling molecule produced in skeletal muscle coordinating energy metabolism

Author

  • Kristoffer Ström
  • David Morales-Alamo
  • Filip Ottosson
  • Anna Edlund
  • Line Hjort
  • Sine W. Jörgensen
  • Peter Almgren
  • Yuedan Zhou
  • Marcos Martin-Rincon
  • Carl Ekman
  • Alberto Pérez-López
  • Ola Ekström
  • Ismael Perez-Suarez
  • Markus Mattiasson
  • Pedro De Pablos-Velasco
  • Nikolay Oskolkov
  • Emma Ahlqvist
  • Nils Wierup
  • Lena Eliasson
  • Allan Vaag
  • Leif Groop
  • Karin G. Stenkula
  • Céline Fernandez
  • Jose A.L. Calbet
  • Hans Christer Holmberg
  • Ola Hansson

Summary, in English

Obesity is a major health problem, and although caloric restriction and exercise are successful strategies to lose adipose tissue in obese individuals, a simultaneous decrease in skeletal muscle mass, negatively effects metabolism and muscle function. To deeper understand molecular events occurring in muscle during weight-loss, we measured the expressional change in human skeletal muscle following a combination of severe caloric restriction and exercise over 4 days in 15 Swedish men. Key metabolic genes were regulated after the intervention, indicating a shift from carbohydrate to fat metabolism. Nicotinamide N-methyltransferase (NNMT) was the most consistently upregulated gene following the energy-deficit exercise. Circulating levels of N1-methylnicotinamide (MNA), the product of NNMT activity, were doubled after the intervention. The fasting-fed state was an important determinant of plasma MNA levels, peaking at ~18 h of fasting and being lowest ~3 h after a meal. In culture, MNA was secreted by isolated human myotubes and stimulated lipolysis directly, with no effect on glucagon or insulin secretion. We propose that MNA is a novel myokine that enhances the utilization of energy stores in response to low muscle energy availability. Future research should focus on applying MNA as a biomarker to identify individuals with metabolic disturbances at an early stage.

Department/s

  • Genomics, Diabetes and Endocrinology
  • Cardiovascular Research - Hypertension
  • Diabetes - Islet Cell Exocytosis
  • Diabetes - Cardiovascular Disease
  • Neuroendocrine Cell Biology
  • Glucose Transport and Protein Trafficking
  • Ophthalmology, Lund
  • EXODIAB: Excellence of Diabetes Research in Sweden

Publishing year

2018-12-01

Language

English

Publication/Series

Scientific Reports

Volume

8

Issue

1

Document type

Journal article

Publisher

Nature Publishing Group

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Genomics, Diabetes and Endocrinology
  • Cardiovascular Research - Hypertension
  • Diabetes - Islet Cell Exocytosis
  • Diabetes - Cardiovascular Disease
  • Neuroendocrine Cell Biology
  • Glucose Transport and Protein Trafficking

ISBN/ISSN/Other

  • ISSN: 2045-2322